Forum for Science, Industry and Business

A New Dawn in Scientific Research

The Science and Technology Facilities Council has been formed from the merger of the Council for the Central Laboratory of the Research Councils [CCLRC] and the Particle Physics and Astronomy Research Council [PPARC]. The Council’s remit will cover all the programmes, activities and facilities previously operated by CCLRC and PPARC, plus responsibility for research in nuclear physics which has been transferred from the Engineering and Physical Sciences Research Council [EPSRC].

Commenting on the new council Professor Keith Mason, Chief Executive Officer said, “My ambition for the new Council is to shape a future in which the science we support, the facilities we operate, the technologies we develop, and the way we interact with industry and run our business are envied both nationally and internationally.

CCLRC and PPARC both had significant achievements and a reputation for world-class research, but we can do more. We have a huge opportunity to develop a really coherent strategy for ‘big science’, to increase our influence in international organisations and make a step change in the exploitation of the resulting technology.

The Science and Technology Facilities Council has the chance to make a real difference to the competitive performance of the UK science and engineering base, and to the UK economy”.

The Council has a wide ranging science portfolio including astronomy, particle physics, particle astrophysics, nuclear physics, space science, synchrotron radiation, neutron sources and high power lasers. In addition the Council operates three internationally renowned laboratories: The Rutherford Appleton Laboratory in Oxfordshire; The Daresbury Laboratory in Cheshire; and the UK Astronomy Technology Centre in Edinburgh.

The Rutherford Appleton and Daresbury facilities are located on the Harwell and Daresbury Science and Innovation Campuses respectively, enabling neighbouring industrial and public sector businesses to develop and commercialise innovative technologies developed at each of the laboratories.

Background Notes

1.The Science and Technology Facilities Council will have a budget circa £500M.

2.The Council’s website is at http://www.scitech.ac.uk

Science and Technology Facilities Council

The Science and Technology Facilities Council ensures the UK retains its leading place on the world stage by delivering world-class science; accessing and hosting international facilities; developing innovative technologies; and increasing the socio-economic impact of its research through effective knowledge-exchange partnerships.

The Council has a broad science portfolio including Astronomy, Particle Physics, Particle Astrophysics, Nuclear Physics, Space Science, Synchrotron Radiation, Neutron Sources and High Power Lasers. In addition the Council will manage and operate three internationally renowned laboratories:

Peter Barratt | alfa
Further information:
http://www.stfc.ac.uk

Im Focus: New Method of Characterizing Graphene

Scientists have developed a new method of characterizing graphene’s properties without applying disruptive electrical contacts, allowing them to investigate both the resistance and quantum capacitance of graphene and other two-dimensional materials. Researchers from the Swiss Nanoscience Institute and the University of Basel’s Department of Physics reported their findings in the journal Physical Review Applied.

Graphene consists of a single layer of carbon atoms. It is transparent, harder than diamond and stronger than steel, yet flexible, and a significantly better...

Im Focus: Strathclyde-led research develops world's highest gain high-power laser amplifier

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...